Conclusions: ALK4 haplodeficiency reduces cardiac inflammation, improves cardiac function, and finally reduces the vulnerability of ventricular arrhythmia in the inflammatory stage after MI. The gene discussed is ACVR1B; the disease is Ventricular arrhythmia.